Hamilton Lane Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-87,329
Closed -$532K 66
2019
Q3
$532K Sell
87,329
-56,896
-39% -$320K 0.22% 36
2019
Q2
$603K Sell
144,225
-200,056
-58% -$1.05M 0.3% 32
2019
Q1
$2.17M Buy
+344,281
New +$2.41M 1.15% 19

Other funds holding NPTN

Hamilton Lane Advisors's NPTN Position: Q4 2019 in Review

Hamilton Lane Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q4 2019, closing a stake of 87,329 shares — an estimated $532K sold.

Hamilton Lane Advisors first reported a position in NPTN in Q1 2019 and held it in 3 quarters. The position peaked at $2.17M in Q1 2019. 126 funds tracked by Wall St. Rank hold NPTN as of Q4 2019.

  • Hamilton Lane Advisors reported no remaining NEOPHOTONICS CORP position as of Q4 2019 after selling out during the quarter.
  • Hamilton Lane Advisors sold 87,329 NEOPHOTONICS CORP shares in Q4 2019, an estimated $532K.
  • Hamilton Lane Advisors first reported a position in NEOPHOTONICS CORP in Q1 2019 and held it in 3 quarters.
  • Hamilton Lane Advisors's NEOPHOTONICS CORP position peaked at $2.17M in Q1 2019.
  • 126 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2019.

Based on Hamilton Lane Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.